Constitutive Androstane Receptor and Peroxisome Proliferator-Activated Receptor a Do Not Perform Liquid-Liquid Phase Separation in Cells

被引:0
|
作者
Zhao, Pengfei [1 ,2 ,3 ,4 ]
Fan, Shicheng [1 ,2 ,3 ,4 ]
Zhou, Yanying [4 ]
Huang, Min [4 ]
Gao, Yue [4 ]
Bi, Huichang [1 ,2 ,3 ,4 ,5 ]
机构
[1] Southern Med Univ, NMPA Key Lab Res & Evaluat Drug Metab, Guangzhou, Peoples R China
[2] Southern Med Univ, Guangdong Prov Key Lab New Drug Screening, Guangzhou, Peoples R China
[3] Southern Med Univ, Sch Pharmaceut Sci, Guangdong Hongkong Macao Joint Lab New Drug Screen, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Sch Pharmaceut Sci, Guangdong Prov Key Lab New Drug Design & Evaluat, Guangzhou, Peoples R China
[5] Peking Univ, Sch Chem Biol & Biotechnol, Shenzhen Grad Sch, State Key Lab Chem Oncogenom, Shenzhen 518055, Peoples R China
基金
中国博士后科学基金; 国家重点研发计划;
关键词
LIVER-REGENERATION; TARGET; ALPHA; TRANSITIONS; MECHANISMS; CAR;
D O I
10.1124/jpet.124.002174
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Constitutive androstane receptor (CAR) and peroxisome proliferatoractivated receptor a (PPARa) are members of the nuclear receptor superfamily, which regulates various physiologic and pathologic processes. Phase separation is a dynamic biophysical process in which biomacromolecules form liquid-like condensates, which have been identified as contributors to many cellular functions, such as signal transduction and transcription regulation. However, the possibility of phase separation for CAR and PPARa remains unknown. This study explored the potential phase separation of CAR and PPARa. The computational analysis utilizing algorithm tools examining the intrinsically disordered regions of CAR induce condensate formation, showed that there was no condensate formation of the fusion protein of Cry2 with CAR or PPARa. Furthermore, phase separation of CAR or PPARa did not occur despite reduced target expression under hyperosmotic stress. In conclusion, these findings revealed that neither the activation of CAR and PPARa nor hyperosmotic stress induces phase separation of CAR and PPARa in cells. SIGNIFICANCE STATEMENT Constitutive androstane receptor (CAR) and peroxisome proliferatoractivated receptor a (PPARa) are key regulators of various functions in the body. This study showed that CAR and PPARa do not exhibit phase separation under hyperosmotic stress or after agonistinduced activation. These findings provide new insights into the CAR and PPARa biology and physiology. and PPARa suggested a limited likelihood of undergoing phase separation. Experimental assays under varying conditions of hyperosmotic stress and agonist treatments confirmed the absence of phase separation for these receptors. Additionally, the optoDroplets assay, which utilizes blue light stimulation to
引用
收藏
页码:88 / 98
页数:11
相关论文
共 50 条
  • [41] Peroxisome proliferator-activated receptor α target genes
    S. Mandard
    M. Müller
    S. Kersten
    Cellular and Molecular Life Sciences CMLS, 2004, 61 : 393 - 416
  • [42] Stabilization of peroxisome proliferator-activated receptor α by the ligand
    Hirotani, M
    Tsukamoto, T
    Bourdeaux, J
    Sadano, H
    Osumi, T
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 288 (01) : 106 - 110
  • [43] Peroxisome Proliferator-Activated Receptor γ and Cardiovascular Diseases
    Takano, Hiroyuki
    Komuro, Issei
    CIRCULATION JOURNAL, 2009, 73 (02) : 214 - 220
  • [44] Peroxisome proliferator-activated receptor δ (PPARδ) in psoriasis
    Westergaard, M
    Henningsen, J
    Johansen, C
    Svendsen, ML
    Iversen, L
    Bolund, L
    Kragballe, K
    Kristiansen, K
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2000, 115 (03) : 582 - 582
  • [45] Ligand selectivity of the peroxisome proliferator-activated receptor α
    Lin, QO
    Ruuska, SE
    Shaw, NS
    Dong, D
    Noy, N
    BIOCHEMISTRY, 1999, 38 (01) : 185 - 190
  • [46] CONSTITUTIVE EXPRESSION OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORγ (PPARγ) IN RAT PERITONEAL MESOTHELIAL CELLS AND REGULATION BY LPS
    Zhang, Yun Fang
    Yang, Xiao
    Zhang, Ya-Jie
    NEPHROLOGY, 2005, 10 : A64 - A65
  • [47] PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR γ AGONIST, CIGLITAZONE, IN HUMAN GLIOBLASTOMA CELLS
    Jung, H.
    Noh, Y.
    Lee, M.
    Kim, D.
    Kim, H.
    Kim, H.
    Cheuh, H.
    Lee, S.
    Yoo, K.
    Sung, K.
    Koo, H.
    NEURO-ONCOLOGY, 2010, 12 (06) : II87 - II87
  • [48] Thyroid hormone regulation of peroxisome proliferator-activated receptorγ coactivator-1 and peroxisome proliferator-activated receptorα gene expression in heart
    McClure, TD
    Ning, XH
    Portman, MA
    PEDIATRIC RESEARCH, 2002, 51 (04) : 36A - 36A
  • [49] Increased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor δ from Peroxisome proliferator-activated receptor γ in the ob/obmouse
    Lee D Roberts
    David G Hassall
    Deborah A Winegar
    John N Haselden
    Andrew W Nicholls
    Julian L Griffin
    Genome Medicine, 1
  • [50] Expression and function of peroxisome proliferator-activated receptor-γ in mesangial cells
    Nicholas, SB
    Kawano, Y
    Wakino, S
    Collins, AR
    Hsueh, WA
    HYPERTENSION, 2001, 37 (02) : 722 - 727